KetamineHQ

Ketamine Therapy for Anxiety: Does It Work?

3 min read·Updated August 2026
This guide is general information, not medical advice. Ketamine therapy isn't right for everyone — talk to a licensed clinician about your specific situation.

Anxiety disorders are among the most common reasons people now walk into ketamine clinics — and among the least discussed in the research literature. Ketamine's evidence for depression is substantial; for anxiety it's early-stage but genuinely encouraging. Here's an honest look at what's known.

What the research shows

Ketamine is off-label for all anxiety disorders. The most notable studies:

  • New Zealand researchers (Glue and colleagues) ran a series of trials in treatment-resistant generalized anxiety disorder (GAD) and social anxiety disorder (SAD). In a 2017 double-blind study, weekly ketamine doses produced dose-related reductions in anxiety symptoms, with effects appearing within an hour and persisting up to a week.
  • A 2018 randomized trial of ketamine in social anxiety disorder found significantly greater symptom reduction versus placebo in the first two weeks after infusion.
  • A large share of the depression trials also tracked anxious symptoms, and anxious depression — historically harder to treat — appears to respond to ketamine about as well as non-anxious depression.

What's missing: large multi-site trials, long-term outcome data, and studies of panic disorder specifically. If a clinic tells you ketamine is "proven" for anxiety, that's overselling. If they tell you there's meaningful early evidence and many patients report substantial relief, that's fair.

How anxiety treatment typically differs from depression protocols

In practice, most clinics use the same backbone: an initial series of IV infusions (commonly around six over two to three weeks at roughly 0.5 mg/kg), followed by maintenance as needed. Some differences worth knowing:

  • Effects may be shorter-lived. In the GAD/SAD trials, relief typically lasted days to about a week per dose, which is why some protocols use ongoing maintenance dosing rather than a one-time series.
  • The acute experience can itself feel anxious. Ketamine's dissociative effects — feeling detached from your body or surroundings — are usually neutral-to-pleasant but can spike anxiety in the first sessions, especially for people prone to panic. Experienced clinics start conservatively and keep staff nearby. Read what to expect at your first session so nothing surprises you.
  • Blood pressure rises transiently during dosing, which matters if your anxiety has a strong physical component; clinics monitor this.

Ketamine is not a benzodiazepine replacement

One important interaction to know about: benzodiazepines (Xanax, Ativan, Klonopin, Valium) appear to blunt ketamine's antidepressant and anti-anxiety effects in several analyses. Many clinics ask patients to skip or reduce benzodiazepine doses in the 24 hours before a session. Never adjust prescribed medication on your own — but do disclose everything you take, because a clinic that doesn't ask about benzodiazepines during screening isn't screening carefully. More red flags to watch for are in our clinic-selection guide.

Who tends to be a reasonable candidate

Ketamine for anxiety generally makes sense to consider when:

  1. You've tried first-line treatments — SSRIs/SNRIs and cognitive behavioral therapy — without adequate relief
  2. Your anxiety co-occurs with depression (the strongest evidence zone)
  3. You can commit to the logistics: clinic visits, a ride home, and possibly ongoing maintenance

It's a weaker fit as a first treatment ever tried, or when anxiety is mild and situational. If you're unsure where your symptoms fall, the GAD-7 anxiety screening is the standard two-minute questionnaire clinicians use.

Cost and coverage

Since anxiety treatment is off-label, insurance won't cover the ketamine itself, and Spravato's FDA approval covers depression indications only — an anxiety diagnosis alone won't qualify you. Expect cash-pay pricing; see how much ketamine therapy costs and our insurance guide for numbers and partial-reimbursement strategies.

Bottom line

The evidence for ketamine in anxiety is younger than for depression, but the early controlled trials, the anxious-depression data, and widespread clinical experience point in the same direction: meaningful, fast relief for a substantial share of patients, with duration being the main limitation. Go in with realistic expectations, disclose all medications, and choose a clinic that screens carefully.

When you're ready to talk to someone, browse clinics near you and ask specifically about their experience treating anxiety rather than depression alone.